The Ensign Group (ENSG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting is scheduled for May 15, 2025, with four key proposals: election of directors, ratification of Deloitte & Touche LLP as auditor, advisory approval of executive compensation, and approval of an amendment to the 2022 Omnibus Incentive Plan.
2024 saw record financial and operational performance, with revenue up 14.2% and occupancy rates rising to 81.3%.
The company expanded by adding 31 operations and 17 real estate properties, entering Tennessee.
Strong liquidity was maintained, with $347.2 million in operating cash flow and continued dividend growth.
Voting matters and shareholder proposals
Shareholders will vote on four proposals: electing four directors, ratifying the auditor, approving executive compensation, and amending the incentive plan.
The board recommends voting FOR all proposals.
Shareholders may submit proposals for the 2026 meeting by December 5, 2025, and can nominate directors per bylaw procedures.
Board of directors and corporate governance
The board is classified into three staggered classes, with six of nine directors deemed independent.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Quality Assurance and Compliance.
The board has a Lead Independent Director and regularly meets in executive session.
Directors possess expertise in leadership, finance, healthcare, risk management, and public policy.
The board actively oversees risk, succession planning, and engages with shareholders throughout the year.
Latest events from The Ensign Group
- Strong growth, robust acquisitions, and proactive regulatory management drive future upside.ENSG
Oppenheimer 36th Annual Healthcare MedTech & Services Conference19 Mar 2026 - Record revenue, earnings, and occupancy drive double-digit FY26 growth outlook.ENSG
Q4 20256 Feb 2026 - Q3 revenue up 15%, net income up 22.8%, and guidance raised amid record occupancy and expansion.ENSG
Q3 20245 Feb 2026 - Record Q2 growth, raised 2024 guidance, and continued disciplined expansion.ENSG
Q2 20242 Feb 2026 - Growth is fueled by leadership, local empowerment, and disciplined acquisitions amid a stable regulatory outlook.ENSG
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Record 2024 results and strong 2025 outlook driven by growth, acquisitions, and financial strength.ENSG
Q4 202426 Dec 2025 - Q1 2025 revenue up 16.1%, net income up 16.6%, and 2025 guidance raised after record growth.ENSG
Q1 202522 Dec 2025 - Director elections, auditor ratification, and incentive plan amendment up for shareholder vote.ENSG
Proxy Filing2 Dec 2025 - Growth continues through acquisitions, innovation, and strategic real estate partnerships.ENSG
RBC Capital Markets Global Healthcare Conference 202524 Nov 2025